Terlipressin effect on hepatorenal syndrome: Updated meta‐analysis of randomized controlled trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Terlipressin effect on hepatorenal syndrome: Updated meta‐analysis of randomized controlled trials

Published:2021-07 Issue:8 Volume:5 Page:896-901
ISSN:2397-9070
Container-title:JGH Open
language:en
Short-container-title:JGH Open

Author:

Mohamed Mohamed M G¹^ORCID,Rauf Abdul¹,Adam Abubakr²,Kheiri Babikir³,Lacasse Alexandre¹,El‐Halawany Hani⁴

Affiliation:

1. Internal Medicine Department SSM Health St. Mary's Hospital‐St. Louis St. Louis Missouri USA

2. Hospital Medicine Department, School of Medicine University of Missouri Colombia Missouri USA

3. Department of Cardiology, Knight Cardiovascular Institute Oregon Health & Science University Portland Oregon USA

4. Department of Gastroenterology, Hepatobiliary and Endoscopy SSM Health St. Mary's Hospital‐St. Louis St. Louis Missouri USA

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jgh3.12600

Reference26 articles.

1. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis;Salerno F;Gut,2007

2. Terlipressin in hepatorenal syndrome: Evidence for present indications

3. Terlipressin: Current and emerging indications in chronic liver disease

4. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis

5. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Mortality Rates of Vasoconstrictor Agents in the Management of Hepatorenal Syndrome: A Systematic Review and Meta-Analysis;Cureus;2024-08-16

2. Management of hepatorenal syndrome and treatment-related adverse events;Current Medical Research and Opinion;2024-06-13

3. Features of the course of hepatorenal syndrome in decompensated portal hypertension (case report);GASTROENTEROLOGY;2024-06-12

4. Hepatorenal syndrome: Current concepts and future perspectives;Clinical and Molecular Hepatology;2023-10-01

5. A Systematic Review of the Emerging Treatment for Hepatorenal Syndrome With a Principal Focus on Terlipressin: A Recent FDA-Approved Drug;Cureus;2023-07-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3